[Editor’s Note: Army Mad Scientist hosts monthly speaker series events with folks from all around the national security apparatus, where they provide insights on the future operational environment the Army will face. On August 18th, 2026, Army Mad Scientist hosted Dr. James Giordano, a biowarfare expert from the National Defense University, for a Speaker Series event where he described the increasing challenge of biowarfare in a democratized environment and ways to slow it down, or “brake” it. Aside from the many new, rather complex words added to our lexicon here at Mad Scientist, there were a number of other key takeaways from the talk — Read on!]
About the Speaker: Dr. James Giordano is head of the Center for Strategic Deterrence and Weapons of Mass Destruction Studies, Institute for National Strategic Studies (INSS), National Defense University. He is Professor Emeritus in the Departments of Neurology and Biochemistry, and Senior Scholar Emeritus of the Pellegrino Center for Clinical Bioethics of Georgetown University Medical Center, Washington, DC. A widely published author of over 350 peer-reviewed papers in the international scientific literature, and 25 governmental reports, his recent books include Brains and Bioethics; Neuroscience, Neuroculture and Neuroethics; and Neurotechnology in National Security and Defense: Technical Considerations, Neuroethical Concerns.
Dr. Giordano received a Ph.D. in biopsychology from the City University of New York, a Master of Arts in neuropsychology from Norwich University; a B.Sc. in physiological psychology from St. Peter’s College; completed post-doctoral training in neuropathology and toxicology at the Johns Hopkins University Medical Center, and is currently completing a D.Phil. in political philosophy of science at the East Bavaria Technical University-Regensburg, Germany. He frequently lectures in German and Italian.
Here are the key takeaways from the talk, described below in the following bullet points:
- The Asymmetric Deterrence Challenge (No Offensive In-Kind Mirror): Because the United States and its international allies maintain a strict legal and ethical prohibition against possessing or developing offensive biological weapons, classical symmetrical deterrence, where an adversary’s action is met with an identical in-kind retaliatory strike, is impossible. Furthermore, responding to non-nuclear biological incursions with nuclear or high-yield kinetic weapons risks altering global nuclear stability doctrines and falling into adversary narrative traps. As a result, biodeterrence requires a paradigm shift toward an asymmetric, non-in-kind strategy that maintains moral legitimacy and strategic sustainability without relying on an offensive bioweapons inventory.
- Convergence of Advanced Biosciences and Generative AI: The modern biothreat landscape is fundamentally altered by the convergence of synthetic genomics, material chemistry, big data, and generative/agentic artificial intelligence. This technological synthesis dramatically compresses research-and-development design cycles from years down to weeks, enabling the rapid digital formulation of novel foldable proteins, peptides, and stable delivery mechanisms. Additionally, this environment gives rise to a secondary “AI versus AI” operational front, where adversary machine-learning algorithms are deployed to generate operational deceptions, mask anomalous genetic engineering, and evade allied biosurveillance systems.
- The Attribution Gap and Adversary “Commercial Veiling”: Biological weapons
present unique operational hurdles due to their long latency periods, diffuse onset, and deliberate design to mimic naturally occurring disease outbreaks, which complicates technical and forensic attribution within political and military decision timelines. Competitor states actively exploit this ambiguity through “commercial veiling,” which is shielding state-directed bioweapons research under the civilian guise of healthcare, agricultural research, or personalized precision medicine. By shifting research discoveries into commercial intellectual property (IP), foreign states can frame standard international arms-control inquiries as unlawful industrial espionage, thereby avoiding convention oversight.
- Operationalizing “Left of Bang” Deterrence via the 4 D’s: To counter threats before deployment, allied defense posture focuses on proactive, left-of-bang deterrence structured around four progressive operational mechanisms: Disruption (interdicting materials, funding, and scientific talent), Delay (introducing logistical and administrative friction into adversary workflows), Defer (shifting the adversary’s economic and strategic cost-benefit calculus), and Disenfranchisement. By dragging out adversary development timelines, allied intelligence can deploy persistent surveillance to develop targeted, upstream medical countermeasures that neutralize the bioagent upon completion, rendering the adversary’s entire investment strategically useless.
- The Proportionality Decision Triad and Jus Contra Bellum: Preventive left-of-bang engagements are governed by an integrated ethical and analytical decision framework to ensure actions remain lawful and proportional. This triad combines Sedgwick Proportionality (assessing necessity, operational efficacy, and the reversibility of actions), Fuzzy Set Theory (applying graded, continuous mathematical scaling to variables like attribution confidence and threat imminence rather than relying on binary pass/fail gates), and the Principle of Double Effect (PDE). Anchored in jus contra bellum principles, this framework ethically justifies calibrated preventive interventions intended to stop escalation into frank military warfare.
If you enjoyed this post, check out the T2COM G-2’s Operational Environment Enterprise web page, brimming with authoritative information on the Operational Environment and how our adversaries fight.
Disclaimer: The views expressed in this blog post do not necessarily reflect those of the U.S. Department of War, Department of the Army, or the U.S. Army Transformation and Training Command (T2COM).
